Technology | Peripheral Artery Disease (PAD) | July 18, 2016

SunTech Medical Receives FDA Approval for CT40 Spot-Check Device

Device provides automated BP, temperature and Sp02 results with high accuracy

SunTech Medical, SunTech CT40 sot-check vital signs device, FDA approval

July 18, 2016 — Blood pressure technology company SunTech Medical received U.S. Food and Drug Administration (FDA) approval for distribution of its next generation spot-check vital signs device,  the SunTech CT40. Driven by SunTech’s clinical-grade Advantage BP technology, the new spot-check vital signs device provides accurate and reliable automated measurements of blood pressure, temperature and pulse oximetry with clinical-grade performance, advanced features and digital connectivity.

The instrument’s modular design allows clinicians to easily make adaptations to the device, enabling them to add thermometry, SpO2 and Wi-Fi while in the field and based solely on the needs of their patient. Available modules include Covidien’s FILAC 3000 thermometry and Masimo’s SET Sp02 technology.

Another feature of the device is SunTech’s Customizable BP Averaging. BP averaging is a key component to accurate blood pressure measurement and used in the recent SPRINT trial conducted by the National Institute of Health (NIH). It is rapidly becoming the new standard of care, with improved accuracy and reduced white coat response. SunTech’s Customizable BP Averaging allows clinicians to automate the process of taking and averaging multiple office BP measurements, while setting their own averaging protocol that fits best into their practice workflow. The device also allows users to verify automated readings using a stethoscope without removing the cuff for consistent patient BP measurements.

The SunTech CT40 connects to a network via Ethernet or optional Wi-Fi, and uses industry-standard IHE profiles to facilitate communication of patient information and measurement data with the electronic medical record (EMR) system. The device’s built-in memory can store up to 99 vital signs charting sessions and users can also easily document patient’s measurements electronically to avoid transcription errors.

A mobile stand is available to facilitate room-to-room relocation. A barcode reader option is available for easy data entry, as well as a thermal printer for hard copies of vital signs measurements.

For more information: www.suntechmed.com

Related Content

World Heart Federation Launches Global Roadmap on Cardiovascular Disease Prevention Among Diabetics
News | Cardiac Diagnostics | September 04, 2019
At the European Society of Cardiology (ESC) Congress 2019 together with the World Congress of Cardiology, the World...
Insomnia Tied to Higher Risk of Heart Disease and Stroke

Image courtesy of the American Heart Association

News | Cardiac Diagnostics | August 19, 2019
People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke,...
Evolutionary Gene Loss May Help Explain Human Predisposition to Heart Attacks
News | Cardiac Diagnostics | July 29, 2019
The loss of a single gene two to three million years ago in our ancestors may have resulted in a heightened risk of...
U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack, according to research...
HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy
News | Cardiac Diagnostics | May 14, 2019
The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and...
New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
Overlay Init